Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Amanda C Guidon, M.D.


Brown University, Providence, RIBA05/2000Comparative Literature
University of Rochester School of Medicine, Rochester, NYMD05/2007Medicine
Duke University Medical Center, Durham, NC06/2013Internship, Neurology Residency, Neuromuscular Fellowships
T.H. Chan Harvard School of Public Health, Boston, MAMPH08/2021Clinical Effectiveness


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Suh J, Clarke V, Amato AA, Guidon AC. Safety and outcomes of eculizumab for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice. Muscle Nerve. 2022 09; 66(3):348-353. PMID: 35684980.
    Citations:    Fields:    
  2. Rhee JY, Torun N, Neilan TG, Guidon AC. Consider Myocarditis When Patients Treated with Immune Checkpoint Inhibitors Present with Ocular Symptoms. Oncologist. 2022 05 06; 27(5):e402-e405. PMID: 35348772; PMCID: PMC9074998.
    Citations:    Fields:    Translation:Humans
  3. London ZN, Gable KL, Govindarajan R, Guidon AC, Gwathmey KG, Hehir MK, Imperioli M, Laughlin RS, Price RS, Sakamuri S, Sokol J, Baer M. The neuromuscular fellowship portal and match. Muscle Nerve. 2022 06; 65(6):640-645. PMID: 35213933; PMCID: PMC9314681.
    Citations:    Fields:    
  4. Burton LB, Eskian M, Guidon AC, Reynolds KL. A review of neurotoxicities associated with immunotherapy and a framework for evaluation. Neurooncol Adv. 2021 Nov; 3(Suppl 5):v108-v120. PMID: 34859238.
    Citations: 1     
  5. Zubiri L, Molina GE, Mooradian MJ, Cohen J, Durbin SM, Petrillo L, Boland GM, Juric D, Dougan M, Thomas MF, Faje AT, Rengarajan M, Guidon AC, Chen ST, Okin D, Medoff BD, Nasrallah M, Kohler MJ, Schoenfeld SR, Karp-Leaf RS, Sise ME, Neilan TG, Zlotoff DA, Farmer JR, Bardia A, Sullivan RJ, Blum SM, Semenov YR, Villani AC, Reynolds KL. Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer. J Immunother Cancer. 2021 09; 9(9). PMID: 34544895; PMCID: PMC8454442.
    Citations: 1     Fields:    Translation:Humans
  6. Doughty CT, Suh J, David WS, Amato AA, Guidon AC. Retrospective analysis of safety and outcomes of rituximab for myasthenia gravis in patients =65 years old. Muscle Nerve. 2021 12; 64(6):651-656. PMID: 34378210.
    Citations: 1     Fields:    Translation:Humans
  7. Guidon AC, Muppidi S, Nowak RJ, Guptill JT, Hehir MK, Ruzhansky K, Burton LB, Post D, Cutter G, Conwit R, Mejia NI, Kaminski HJ, Howard JF. Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE). Muscle Nerve. 2021 09; 64(3):270-276. PMID: 33959997; PMCID: PMC9057373.
    Citations: 2     Fields:    Translation:Humans
  8. Guidon AC, Burton LB, Chwalisz BK, Hillis J, Schaller TH, Amato AA, Betof Warner A, Brastianos PK, Cho TA, Clardy SL, Cohen JV, Dietrich J, Dougan M, Doughty CT, Dubey D, Gelfand JM, Guptill JT, Johnson DB, Juel VC, Kadish R, Kolb N, LeBoeuf NR, Linnoila J, Mammen AL, Martinez-Lage M, Mooradian MJ, Naidoo J, Neilan TG, Reardon DA, Rubin KM, Santomasso BD, Sullivan RJ, Wang N, Woodman K, Zubiri L, Louv WC, Reynolds KL. Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors. J Immunother Cancer. 2021 07; 9(7). PMID: 34281989.
    Citations: 18     Fields:    Translation:Humans
  9. Reynolds KL, Arora S, Elayavilli RK, Louv WC, Schaller TH, Khandelwal A, Rothenberg M, Khozin S, Guidon AC, Dougan M, Zubiri L, Petrillo L, Sise ME, Villani AC, Johnson DB, Rahma O, Sharon E. Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data. J Immunother Cancer. 2021 07; 9(7). PMID: 34215691.
    Citations: 5     Fields:    Translation:Humans
  10. Drobni ZD, Murphy SP, Alvi RM, Lee C, Gong J, Mosarla RC, Rambarat PK, Hartmann SB, Gilman HK, Zubiri L, Raghu VK, Sullivan RJ, Zafar A, Zlotoff DA, Sise ME, Guidon AC, Reynolds KL, Dougan M, Neilan TG. Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors. Immunother Adv. 2021 Jan; 1(1):ltab014. PMID: 34541581; PMCID: PMC8444991.
    Citations: 2     
  11. Molina GE, Zubiri L, Cohen JV, Durbin SM, Petrillo L, Allen IM, Murciano-Goroff YR, Dougan M, Thomas MF, Faje AT, Rengarajan M, Guidon AC, Chen ST, Okin D, Medoff BD, Nasrallah M, Kohler MJ, Schoenfeld SR, Karp Leaf RS, Sise ME, Neilan TG, Zlotoff DA, Farmer JR, Mooradian MJ, Bardia A, Mai M, Sullivan RJ, Semenov YR, Villani AC, Reynolds KL. Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018. Oncologist. 2021 06; 26(6):514-522. PMID: 33655682; PMCID: PMC8176966.
    Citations: 5     Fields:    Translation:Humans
  12. Jiwa NS, Lawrence DP, Guidon AC. Dual hereditary and immune-mediated neuromuscular diagnoses after cancer immunotherapy. Muscle Nerve. 2021 03; 63(3):E21-E24. PMID: 33314145.
    Citations: 1     Fields:    Translation:Humans
  13. Muppidi S, Guptill JT, Jacob S, Li Y, Farrugia ME, Guidon AC, Tavee JO, Kaminski H, Howard JF, Cutter G, Wiendl H, Maas MB, Illa I, Mantegazza R, Murai H, Utsugisawa K, Nowak RJ. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol. 2020 12; 19(12):970-971. PMID: 33212055.
    Citations: 27     Fields:    Translation:HumansCells
  14. Anand P, Slama MCC, Kaku M, Ong C, Cervantes-Arslanian AM, Zhou L, David WS, Guidon AC. Comment on COVID-19 in patients with myasthenia gravis: Author response. Muscle Nerve. 2020 12; 62(6):E87-E88. PMID: 32954519.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  15. Doughty CT, Guidon AC. Diagnostic testing for ocular myasthenia gravis: Stronger together. Neurology. 2020 09 29; 95(13):563-564. PMID: 32788244.
    Citations:    Fields:    Translation:Humans
  16. Anand P, Slama MCC, Kaku M, Ong C, Cervantes-Arslanian AM, Zhou L, David WS, Guidon AC. COVID-19 in patients with myasthenia gravis. Muscle Nerve. 2020 08; 62(2):254-258. PMID: 32392389; PMCID: PMC7272991.
    Citations: 54     Fields:    Translation:HumansCellsPHPublic Health
  17. Dubey D, Guidon A. Reply to "Value of Onconeural Antibodies in Checkpoint Inhibitor-Related Toxicities". Ann Neurol. 2020 07; 88(1):200-201. PMID: 32368808.
    Citations: 1     Fields:    Translation:Humans
  18. Strohbehn IA, Lee M, Seethapathy H, Chute D, Rahma O, Guidon A, Neilan TG, Zlotoff DA, Okin D, Rengarajan M, Reynolds K, Sise ME. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients on Dialysis: A Retrospective Case Series. Am J Kidney Dis. 2020 08; 76(2):299-302. PMID: 32417401.
    Citations: 5     Fields:    Translation:Humans
  19. Howard JF, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ, Barohn R, Dimachkie M, Pasnoor M, Farmakidis C, Liu T, Colgan S, Benatar MG, Bertorini T, Pillai R, Henegar R, Bromberg M, Gibson S, Janecki T, Freimer M, Elsheikh B, Matisak P, Genge A, Guidon A, David W, Habib AA, Mathew V, Mozaffar T, Hinton JL, Hewitt W, Barnett D, Sullivan P, Ho D, Howard JF, Traub RE, Chopra M, Kaminski HJ, Aly R, Bayat E, Abu-Rub M, Khan S, Lange D, Holzberg S, Khatri B, Lindman E, Olapo T, Sershon LM, Lisak RP, Bernitsas E, Jia K, Malik R, Lewis-Collins TD, Nicolle M, Nowak RJ, Sharma A, Roy B, Nye J, Pulley M, Berger A, Shabbir Y, Sachdev A, Patterson K, Siddiqi Z, Sivak M, Bratton J, Small G, Kohli A, Fetter M, Vu T, Lam L, Harvey B, Wolfe GI, Silvestri N, Patrick K, Zakalik K, Duda PW, MacDougall J, Farzaneh-Far R, Pontius A, Hoarty M. Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. JAMA Neurol. 2020 05 01; 77(5):582-592. PMID: 32065623; PMCID: PMC7042797.
    Citations: 35     Fields:    Translation:HumansCTClinical Trials
  20. Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020 06 02; 94(22):959-969. PMID: 32284362.
    Citations: 99     Fields:    Translation:HumansPHPublic Health
  21. Jacob S, Muppidi S, Guidon A, Guptill J, Hehir M, Howard JF, Illa I, Mantegazza R, Murai H, Utsugisawa K, Vissing J, Wiendl H, Nowak RJ. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020 05 15; 412:116803. PMID: 32247193.
    Citations: 56     Fields:    Translation:HumansCellsPHPublic Health
  22. Dubey D, David WS, Reynolds KL, Chute DF, Clement NF, Cohen JV, Lawrence DP, Mooradian MJ, Sullivan RJ, Guidon AC. Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum. Ann Neurol. 2020 05; 87(5):659-669. PMID: 32086972.
    Citations: 36     Fields:    Translation:Humans
  23. Guidon AC. Lambert-Eaton Myasthenic Syndrome, Botulism, and Immune Checkpoint Inhibitor-Related Myasthenia Gravis. Continuum (Minneap Minn). 2019 Dec; 25(6):1785-1806. PMID: 31794471.
    Citations: 4     Fields:    Translation:Humans
  24. Zubiri L, Allen IM, Taylor MS, Guidon AC, Chen ST, Schoenfeld SR, Neilan TG, Sise ME, Mooradian MJ, Rubin KM, Leaf RK, Parikh AR, Faje A, Gainor JF, Cohen JV, Fintelmann FJ, Kohler MJ, Dougan M, Reynolds KL. Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy. Oncologist. 2019 Nov 21. PMID: 31754069.
  25. Zubiri L, Allen IM, Taylor MS, Guidon AC, Chen ST, Schoenfeld SR, Neilan TG, Sise ME, Mooradian MJ, Rubin KM, Leaf RK, Parikh AR, Faje A, Gainor JF, Cohen JV, Fintelmann FJ, Kohler MJ, Dougan M, Reynolds KL. Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy. Oncologist. 2020 03; 25(3):e398-e404. PMID: 32162817; PMCID: PMC7066708.
    Citations: 3     Fields:    Translation:Humans
  26. Freeman MW, Guidon AC, Arvikar SL. Case 22-2019: A 65-Year-Old Woman with Myopathy. Reply. N Engl J Med. 2019 10 24; 381(17):1694. PMID: 31644864.
    Citations:    Fields:    Translation:Humans
  27. Suh J, Slawski BR, Long AA, Guidon AC. Rituximab desensitization in two patients with muscle-specific kinase myasthenia gravis. Muscle Nerve. 2019 11; 60(5):E35-E37. PMID: 31469920.
    Citations:    Fields:    Translation:Humans
  28. Dubey D, David WS, Amato AA, Reynolds KL, Clement NF, Chute DF, Cohen JV, Lawrence DP, Mooradian MJ, Sullivan RJ, Guidon AC. Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies. Neurology. 2019 09 10; 93(11):e1093-e1103. PMID: 31405908.
    Citations: 32     Fields:    Translation:Humans
  29. Robbins NM, Mozaffar T, Mammen AL, Liewluck T, Guidon A, Lawson VH. Reader response: Pearls & Oy-sters: Pembrolizumab-induced myasthenia gravis. Neurology. 2019 07 23; 93(4):183-184. PMID: 31332091.
    Citations: 2     Fields:    Translation:Humans
  30. Johnson DB, McDonnell WJ, Gonzalez-Ericsson PI, Al-Rohil RN, Mobley BC, Salem JE, Wang DY, Sanchez V, Wang Y, Chastain CA, Barker K, Liang Y, Warren S, Beechem JM, Menzies AM, Tio M, Long GV, Cohen JV, Guidon AC, O'Hare M, Chandra S, Chowdhary A, Lebrun-Vignes B, Goldinger SM, Rushing EJ, Buchbinder EI, Mallal SA, Shi C, Xu Y, Moslehi JJ, Sanders ME, Sosman JA, Balko JM. A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis. Nat Med. 2019 08; 25(8):1243-1250. PMID: 31332390; PMCID: PMC6689251.
    Citations: 49     Fields:    Translation:HumansCells
  31. Freeman MW, Singh AK, Guidon AC, Arvikar SL, Goldstein RH, Clement NF. Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and Dysphagia. N Engl J Med. 2019 Jul 18; 381(3):275-283. PMID: 31314973.
    Citations: 1     Fields:    Translation:Humans
  32. Guidon AC, Juel VC. Efgartigimod: A novel antibody depletion therapy in myasthenia gravis. Neurology. 2019 06 04; 92(23):1079-1080. PMID: 31118243.
    Citations: 2     Fields:    Translation:Humans
  33. Edmundson C, Guidon AC. Eculizumab: A Complementary addition to existing long-term therapies for myasthenia gravis. Muscle Nerve. 2019 07; 60(1):7-9. PMID: 31074870.
    Citations: 4     Fields:    Translation:Humans
  34. Doughty CT, Guidon AC, Paganoni S, Hedley-Whyte ET. Case 12-2019: A 60-Year-Old Man with Weakness and Difficulty Chewing. N Engl J Med. 2019 Apr 18; 380(16):1566-1574. PMID: 30995378.
    Citations:    Fields:    Translation:Humans
  35. Reynolds KL, Guidon AC. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the Literature. Oncologist. 2019 04; 24(4):435-443. PMID: 30482825; PMCID: PMC6459240.
    Citations: 21     Fields:    Translation:Humans
  36. Guidon AC, Hobson-Webb LD. On the double: Early immunotherapy speeds recovery of ocular myasthenic weakness. Muscle Nerve. 2018 12; 58(6):743-744. PMID: 30106478.
    Citations:    Fields:    Translation:Humans
  37. Verenes M, Stone SL, Hobson-Webb LD, Mhoon JT, Guidon AC, De Jesus-Acosta C, Cartwright MS. Neuromuscular ultrasound findings in eosinophilic fasciitis: A case series and literature review. Muscle Nerve. 2018 08; 58(2):E15-E18. PMID: 29679393.
    Citations:    Fields:    Translation:HumansCells
  38. Edmundson C, Guidon AC. Neuromuscular Disorders in Pregnancy. Semin Neurol. 2017 12; 37(6):643-652. PMID: 29270937.
    Citations: 4     Fields:    Translation:Humans
  39. Howard JF, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol. 2017 12; 16(12):976-986. PMID: 29066163.
    Citations: 143     Fields:    Translation:HumansCTClinical Trials
  40. Burns TM, Smith GA, Allen JA, Amato AA, Arnold WD, Barohn R, Benatar M, Bird SJ, Bromberg M, Chahin N, Ciafaloni E, Cohen JA, Corse A, Crum BA, David WS, Dimberg E, Sousa EA, Donofrio PD, Dyck PJ, Engel AG, Ensrud ER, Ferrante M, Freimer M, Gable KL, Gibson S, Gilchrist JM, Goldstein JM, Gooch CL, Goodman BP, Gorelov D, Gospe SM, Goyal NA, Guidon AC, Guptill JT, Gutmann L, Gutmann L, Gwathmey K, Harati Y, Harper CM, Hehir MK, Hobson-Webb LD, Howard JF, Jackson CE, Johnson N, Jones SM, Juel VC, Kaminski HJ, Karam C, Kennelly KD, Khella S, Khoury J, Kincaid JC, Kissel JT, Kolb N, Lacomis D, Ladha S, Larriviere D, Lewis RA, Li Y, Litchy WJ, Logigian E, Lou JS, MacGowen DJ, Maselli R, Massey JM, Mauermann ML, Mathews KD, Meriggioli MN, Miller RG, Moon JS, Mozaffar T, Nations SP, Nowak RJ, Ostrow LW, Pascuzzi RM, Peltier A, Ruzhansky K, Richman DP, Ross MA, Rubin DI, Russell JA, Sachs GM, Salajegheh MK, Saperstein DS, Scelsa S, Selcen D, Shaibani A, Shieh PB, Silvestri NJ, Singleton JR, Smith BE, So YT, Solorzano G, Sorenson EJ, Srinivasen J, Tavee J, Tawil R, Thaisetthawatkul P, Thornton C, Trivedi J, Vernino S, Wang AK, Webb TA, Weiss MD, Windebank AJ, Wolfe GI. Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine. Muscle Nerve. 2016 Feb; 53(2):165-8. PMID: 26662952.
    Citations: 2     Fields:    Translation:Humans
  41. Guptill JT, Yi JS, Sanders DB, Guidon AC, Juel VC, Massey JM, Howard JF, Scuderi F, Bartoccioni E, Evoli A, Weinhold KJ. Characterization of B cells in muscle-specific kinase antibody myasthenia gravis. Neurol Neuroimmunol Neuroinflamm. 2015 Apr; 2(2):e77. PMID: 25745635.
    Citations: 24     Fields:    
  42. Guidon AC. Comment: A growing role for nerve ultrasound in diagnosis and management of CIDP? Neurology. 2015 Feb 24; 84(8):808. PMID: 25632089.
    Citations: 1     Fields:    Translation:Humans
  43. Massey EW, Guidon AC. Peripheral neuropathies in pregnancy. Continuum (Minneap Minn). 2014 Feb; 20(1 Neurology of Pregnancy):100-14. PMID: 24492813.
    Citations: 1     Fields:    Translation:Humans
  44. Yi JS, Guidon A, Sparks S, Osborne R, Juel VC, Massey JM, Sanders DB, Weinhold KJ, Guptill JT. Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis. J Autoimmun. 2014 Aug; 52:130-8. PMID: 24378287.
    Citations: 35     Fields:    Translation:HumansCells
  45. Guptill JT, Oakley D, Kuchibhatla M, Guidon AC, Hobson-Webb LD, Massey JM, Sanders DB, Juel VC. A retrospective study of complications of therapeutic plasma exchange in myasthenia. Muscle Nerve. 2013 Feb; 47(2):170-6. PMID: 23168720.
    Citations: 7     Fields:    Translation:Humans
  46. Guidon AC, Massey EW. Neuromuscular disorders in pregnancy. Neurol Clin. 2012 Aug; 30(3):889-911. PMID: 22840795.
    Citations: 3     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Guidon's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (180)
Co-Authors (52)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.